Surgery Partners (SGRY) vs Tenet Healthcare (THC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Surgery Partners (SGRY) has outperformed Tenet Healthcare (THC) over the past year, gaining 69.1% versus a gain of 37.1%. Over five years, THC leads with a +247.8% price change compared with -38.8% for SGRY. Tenet Healthcare is the larger company by market cap ($20.95 billion vs $3.50 billion), about 6.0 times the size, while Surgery Partners is growing revenue faster (+6.2% vs +3.1%).
On valuation, Tenet Healthcare trades at a lower forward P/E (13.0x vs 88.4x for Surgery Partners). Tenet Healthcare converts more of its revenue into profit, with a net margin of 11.1% versus -2.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SGRY | THC |
|---|---|---|
| Share price | $26.78 | $263.19 |
| Market cap | $3.50B | $20.95B |
| 1-day change | +0.34% | -0.15% |
| YTD return | +73.33% | +32.44% |
| 1-year return | +69.07% | +37.11% |
| 5-year return | -38.77% | +247.81% |
| P/E ratio (TTM) | — | 7.68 |
| Forward P/E | 88.39 | 12.96 |
| EPS (TTM) | $-0.67 | $34.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.31B | $21.31B |
| Revenue growth (YoY) | +6.24% | +3.07% |
| Net income (latest FY) | $-77.90M | $2.37B |
| Operating margin | 11.77% | 16.46% |
| Net margin | -2.35% | 11.11% |
| 52-week high | $27.23 | $301.44 |
| 52-week low | $11.41 | $157.58 |
| Distance from 52-week high | -1.63% | -12.69% |
| Analyst consensus | hold | buy |
| Avg. price target upside | -8.89% | +17.37% |
| Average volume | 3.87M | 804.49K |
| Shares outstanding | 130.88M | 79.59M |
| Employees | 16,000 | 77,000 |
| Sector | Health Care | Health Care |
| Industry | Hospital/Nursing Management | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Tenet Healthcare is about 6.0 times larger than Surgery Partners by market value ($20.95B vs $3.50B).
- SGRY has outperformed THC by 32.0 percentage points over the past year.
- Tenet Healthcare is more profitable, keeping 11.1 cents of every revenue dollar as net income versus -2.4 cents for Surgery Partners.
About Surgery Partners
SGRY stock →Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Health Care · Hospital/Nursing Management · 16,000 employees
About Tenet Healthcare
THC stock →Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care.
Health Care · Hospital/Nursing Management · 77,000 employees
SGRY vs THC FAQ
Which is bigger, Surgery Partners or Tenet Healthcare?
Tenet Healthcare (THC) is larger, with a market capitalization of $20.95B compared with $3.50B for Surgery Partners (SGRY).
Which stock has performed better over the past year, SGRY or THC?
SGRY returned +69.07% over the past 12 months, compared with +37.11% for THC (price return, excluding dividends). Past performance does not predict future results.
Are Surgery Partners and Tenet Healthcare in the same industry?
Yes. Both are classified in the Hospital/Nursing Management industry within the Health Care sector.